Molecular characteristics of glioblastoma with 1p/19q co-deletion-Reference-Cited by-同舟云学术

Molecular characteristics of glioblastoma with 1p/19q co-deletion

Published:2012-06-27 Issue:3 Volume:29 Page:148-153
ISSN:1433-7398
Container-title:Brain Tumor Pathology
language:en
Short-container-title:Brain Tumor Pathol

Author:

Mizoguchi Masahiro,Yoshimoto Koji,Ma Xinlong,Guan Yanlei,Hata Nobuhiro,Amano Toshiyuki,Nakamizo Akira,Suzuki Satoshi O.,Iwaki Toru,Sasaki Tomio

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Neurology (clinical),Oncology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s10014-012-0107-z.pdf

Reference30 articles.

1. Louis DN, Ohgaki H, Weistler OD et al (2007) WHO Classification of tumours of the central nervous system: International Agency for Research on Cancer (IARC), Lyon

2. Ohgaki H, Kleihues P (2009) Genetic alterations and signaling pathways in the evolution of gliomas. Cancer Sci 100:2235–2241

3. Cairncross JG, Ueki K, Zlatescu MC et al (1998) Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst 90:1473–1479

4. Louis DN, Holland EC, Cairncross JG (2001) Glioma classification: a molecular reappraisal. Am J Pathol 159:779–786

5. Cairncross G (2006) Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: intergroup radiation therapy oncology Group Trial 9402. J Clin Oncol 24:2707–2714

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Principles in the Management of Glioblastoma;Genes;2024-04-17

2. Hemizygous deletion of cyclin-dependent kinase inhibitor 2A/B with p16 immuno-negative and methylthioadenosine phosphorylase retention predicts poor prognosis in IDH-mutant adult glioma;Neuro-Oncology Advances;2024-01-01

3. Dysregulation of inflammasome activation in glioma;Cell Communication and Signaling;2023-09-18

4. Comparative oncology: overcoming human cancer through companion animal studies;Experimental & Molecular Medicine;2023-04-03

5. Clinical Significance of NKD Inhibitor of WNT Signaling Pathway 1 (NKD1) in Glioblastoma;Genetics Research;2023-03-17